BIOMAT Database Logo BIOMAT Database Logo

Preparation of polyethylene glycol-modified streptokinase with disappearance of binding ability towards anti-serum and retention of activity. 1982

A Koide, and S Suzuki, and S Kobayashi

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase

Related Publications

A Koide, and S Suzuki, and S Kobayashi
Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.
January 1979, Enzyme,
A Koide, and S Suzuki, and S Kobayashi
Modification of E. coli L-asparaginase with polyethylene glycol: disappearance of binding ability to anti-asparaginase serum.
July 1978, Biochemical and biophysical research communications,
A Koide, and S Suzuki, and S Kobayashi
Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
October 1983, Life sciences,
A Koide, and S Suzuki, and S Kobayashi
Modification of amino groups in porcine pancreatic elastase with polyethylene glycol in relation to binding ability towards anti-serum and to enzymic activity.
March 1983, Biochemical and biophysical research communications,
A Koide, and S Suzuki, and S Kobayashi
Preparation and Characterization of Modified Soda Lignin with Polyethylene Glycol.
October 2016, Materials (Basel, Switzerland),
A Koide, and S Suzuki, and S Kobayashi
Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM.
January 1999, Bioconjugate chemistry,
A Koide, and S Suzuki, and S Kobayashi
Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity.
January 1981, Enzyme,
A Koide, and S Suzuki, and S Kobayashi
Preparation and characterization of polyethylene-glycol-modified salmon calcitonins.
May 1999, Pharmaceutical development and technology,
A Koide, and S Suzuki, and S Kobayashi
[Interferon alpha-2b modified with polyethylene glycol].
September 2008, Sheng wu gong cheng xue bao = Chinese journal of biotechnology,
A Koide, and S Suzuki, and S Kobayashi
Novel effects with polyethylene glycol modified pharmaceuticals.
April 2002, Cancer treatment reviews,
Copied contents to your clipboard!